A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19

Original Article

O. Mitjà, M. Corbacho-Monné, M. Ubals, A. Alemany, C. Suñer, C. Tebé, A. Tobias, J. Peñafiel, E. Ballana, C.A. Pérez, P. Admella, N. Riera-Martí, P. Laporte, J. Mitjà, M. Clua, L. Bertran, M. Sarquella, S. Gavilán, J. Ara, J.M. Argimon, G. Cuatrecasas, P. Cañadas, A. Elizalde-Torrent, R. Fabregat, M. Farré, A. Forcada, G. Flores-Mateo, C. López, E. Muntada, N. Nadal, S. Narejos, A. Nieto, N. Prat, J. Puig, C. Quiñones, F. Ramírez-Viaplana, J. Reyes-Urueña, E. Riveira-Muñoz, L. Ruiz, S. Sanz, A. Sentís, A. Sierra, C. Velasco, R.M. Vivanco-Hidalgo, J. Zamora, J. Casabona, M. Vall-Mayans, C. González-Beiras, and B. Clotet

N Engl J Med 2021;384:417-427

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
02/03/2021
Course expires: 
02/04/2023

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Saturday, February 4, 2023 - 11:59pm.